Part 2—Therapeutic goods when used, advertised, or presented for supply in a particular way
<table cellspacing="0" cellpadding="0" style="width:100%; margin-right:9pt; margin-left:9pt; border-collapse:collapse; float:left"><thead><tr style="height:2.85pt"><td colspan="3" style="border-top:1.5pt solid #000000; border-bottom:1pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableHeading"><a id="_Hlk128381738"><span>Goods that are therapeutic goods when used, advertised, or presented for supply in a particular way</span></a></p></td></tr><tr style="height:2.85pt"><td style="width:13.02%; border-top:1pt solid #000000; border-bottom:1pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableHeading"><span>Column 1</span></p></td><td style="width:45.56%; border-top:1pt solid #000000; border-bottom:1pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableHeading"><span>Column 2</span></p></td><td style="width:41.42%; border-top:1pt solid #000000; border-bottom:1pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableHeading"><span>Column 3</span></p></td></tr><tr style="height:2.85pt"><td style="width:13.02%; border-top:1pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableHeading"><span>Item</span></p></td><td style="width:45.56%; border-top:1pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableHeading"><span>Goods or classes of goods</span></p></td><td style="width:41.42%; border-top:1pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableHeading"><span>Use, advertising or presentation</span></p></td></tr></thead><tbody><tr style="height:14.15pt"><td style="width:13.02%; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="Tabletext"><span>1A</span></p></td><td style="width:45.56%; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="Tabletext"><span>goods for oral administration that are represented (expressly or by implication) as being for the improvement or maintenance of physical or mental performance in sport, exercise or recreational activity, and that:</span></p><p class="Tabletext" style="margin-right:4.6pt; margin-left:18.15pt; text-indent:-18.15pt"><span>(a)</span><span style="width:7.05pt; text-indent:0pt; display:inline-block"> </span><span>contain, or are represented (expressly or by implication) to</span><span> </span><span>contain, one or more of the following substances (however described or named):</span></p><p class="Tabletext" style="margin-left:39.75pt; text-indent:-21.65pt"><span>(i)</span><span style="width:12.21pt; text-indent:0pt; display:inline-block"> </span><span>a substance included in a schedule to the current Poisons Standard; or</span></p><p class="Tabletext" style="margin-left:39.75pt; text-indent:-21.65pt"><span>(ii)</span><span style="width:9.43pt; text-indent:0pt; display:inline-block"> </span><span>a substance</span><span style="font-size:11pt"> </span><span>expressly identified on the Prohibited List</span><span style="font-size:11pt"> </span><span>that is added as an ingredient to the goods; or</span></p><p class="Tabletext" style="margin-left:39.75pt; text-indent:-21.65pt"><span>(iii)</span><span style="width:6.65pt; text-indent:0pt; display:inline-block"> </span><span>a relevant substance</span><span style="font-size:11pt"> </span><span>that is added as an ingredient to the goods; or</span></p><p class="Tabletext" style="margin-left:39.75pt; text-indent:-21.65pt"><span>(iv)</span><span style="width:7.21pt; text-indent:0pt; display:inline-block"> </span><span>a substance with equivalent pharmacological action to a substance mentioned in subparagraph (i), (ii) or (iii), including those that may be characterised as an active principle, precursor, derivative, salt, ester, ether or stereoisomer; or</span></p><p class="Tabletext" style="margin-left:18.15pt; text-indent:-18.15pt"><span>(b)</span><span style="width:6.49pt; text-indent:0pt; display:inline-block"> </span><span>on or after 30 November 2023, are supplied in the dosage form of a tablet, capsule or pill, other than those goods containing glucose only</span></p></td><td style="width:41.42%; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="Tabletext"><span>when the goods are used, advertised, or presented for supply:</span></p><p class="Tabletext" style="margin-left:18.1pt; text-indent:-18.1pt"><span>(a)</span><span style="width:7pt; text-indent:0pt; display:inline-block"> </span><span>for therapeutic use; or</span></p><p class="Tabletext" style="margin-left:18.1pt; text-indent:-18.1pt"><span>(b)</span><span style="width:6.44pt; text-indent:0pt; display:inline-block"> </span><span>in a way that is likely to be taken to be for therapeutic use;</span></p><p class="Tabletext"><span>including, but not limited to, one or more of the following therapeutic uses:</span></p><p class="Tabletext" style="margin-left:18.1pt; text-indent:-18.1pt"><span>(c)</span><span style="width:7pt; text-indent:0pt; display:inline-block"> </span><span>gaining muscle;</span></p><p class="Tabletext" style="margin-left:18.1pt; text-indent:-18.1pt"><span>(d)</span><span style="width:6.44pt; text-indent:0pt; display:inline-block"> </span><span>increasing mental focus;</span></p><p class="Tabletext" style="margin-left:18.1pt; text-indent:-18.1pt"><span>(e)</span><span style="width:7pt; text-indent:0pt; display:inline-block"> </span><span>increasing metabolism;</span></p><p class="Tabletext" style="margin-left:18.1pt; text-indent:-18.1pt"><span>(f)</span><span style="width:8.11pt; text-indent:0pt; display:inline-block"> </span><span>increasing stamina;</span></p><p class="Tabletext" style="margin-left:18.1pt; text-indent:-18.1pt"><span>(g)</span><span style="width:6.44pt; text-indent:0pt; display:inline-block"> </span><span>increasing testosterone levels, reducing oestrogen levels or otherwise modifying hormone levels;</span></p><p class="Tabletext" style="margin-left:18.1pt; text-indent:-18.1pt"><span>(h)</span><span style="width:6.44pt; text-indent:0pt; display:inline-block"> </span><span>losing weight or fat;</span></p><p class="Tabletext" style="margin-left:18.1pt; text-indent:-18.1pt"><span>(i)</span><span style="width:8.66pt; text-indent:0pt; display:inline-block"> </span><span>preparing for workout;</span></p><p class="Tabletext"><span>(j)</span><span style="width:8.66pt; display:inline-block"> </span><span>recovering from workout</span></p></td></tr><tr style="height:14.15pt"><td style="width:13.02%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="Tabletext"><span>1</span></p></td><td style="width:45.56%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="Tabletext"><span>goods that are labelled or promoted for cosmetic purposes</span></p></td><td style="width:41.42%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="Tabletext"><span>when used, advertised or presented for supply for oral consumption</span></p></td></tr><tr style="height:14.15pt"><td style="width:13.02%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="Tabletext"><span>2</span></p></td><td style="width:45.56%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="Tabletext"><span>goods that contain Trefriw Wells mineral water</span></p></td><td style="width:41.42%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="Tabletext"><span>when used, advertised or presented for supply for therapeutic use:</span></p><p class="Tabletext"><span>(a)</span><span style="width:7pt; display:inline-block"> </span><span>as an iron supplement; and</span></p><p class="Tabletext"><span>(b)</span><span style="width:6.44pt; display:inline-block"> </span><span>in a single use sachet</span></p></td></tr><tr style="height:14.15pt"><td style="width:13.02%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="Tabletext"><span>3</span></p></td><td style="width:45.56%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="Tabletext"><span>goods that:</span></p><p class="Tabletext" style="margin-left:18.15pt; text-indent:-18.15pt"><span>(a)</span><span style="width:7.05pt; text-indent:0pt; display:inline-block"> </span><span>contain one or more of the following folate substances:</span></p><p class="Tabletext" style="margin-left:36.2pt; text-indent:-18.1pt"><span>(i)</span><span style="width:8.66pt; text-indent:0pt; display:inline-block"> </span><span>folic acid; or</span></p><p class="Tabletext" style="margin-left:36.2pt; text-indent:-18.1pt"><span>(ii)</span><span style="width:5.88pt; text-indent:0pt; display:inline-block"> </span><span>folinic acid; or</span></p><p class="Tabletext" style="margin-left:36.2pt; text-indent:-18.1pt"><span>(iii)</span><span style="width:3.1pt; text-indent:0pt; display:inline-block"> </span><span>levomefolic acid; or</span></p><p class="Tabletext" style="margin-left:36.2pt; text-indent:-18.1pt"><span>(iv)</span><span style="width:3.66pt; text-indent:0pt; display:inline-block"> </span><span>any other form of folate that may be characterised as an active principle, precursor, derivative, salt, ester, ether or stereoisomer; and</span></p><p class="Tabletext" style="margin-left:18.15pt; text-indent:-18.15pt"><span>(b)</span><span style="width:6.49pt; text-indent:0pt; display:inline-block"> </span><span>are represented as being food for special medical purposes, or being for dietary management of a disease, disorder or medical condition;</span></p><p class="Tabletext"><span>whether or not the recommended single dose of the goods contains sufficient macronutrients to feed, either exclusively or partially, the person for whom the dose is intended</span></p></td><td style="width:41.42%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="Tabletext"><span>when used, advertised, or presented for supply:</span></p><p class="Tabletext" style="margin-left:18.1pt; text-indent:-18.1pt"><span>(a)</span><span style="width:7pt; text-indent:0pt; display:inline-block"> </span><span>for therapeutic use; or</span></p><p class="Tabletext" style="margin-left:18.1pt; text-indent:-18.1pt"><span>(b)</span><span style="width:6.44pt; text-indent:0pt; display:inline-block"> </span><span>in a way that is likely to be taken to be for therapeutic use;</span></p><p class="Tabletext"><span>including, but not limited to, one or more of the following therapeutic uses:</span></p><p class="Tabletext" style="margin-left:18.1pt; text-indent:-18.1pt"><span>(c)</span><span style="width:7pt; text-indent:0pt; display:inline-block"> </span><span>preventing, curing or alleviating depression;</span></p><p class="Tabletext" style="margin-left:18.1pt; text-indent:-18.1pt"><span>(d)</span><span style="width:6.44pt; text-indent:0pt; display:inline-block"> </span><span>curing or alleviating an inborn error of folate metabolism;</span></p><p class="Tabletext" style="margin-left:18.1pt; text-indent:-18.1pt"><span>(e)</span><span style="width:7pt; text-indent:0pt; display:inline-block"> </span><span>preventing, curing or alleviating folate deficiency;</span></p><p class="Tabletext"><span>and that therapeutic use can be taken to relate to a substance mentioned in paragraph (a) in column 2 of this item</span></p></td></tr></tbody></table>
Schedule 2—Not therapeutic goods
Note: See section 6.